| Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin. | |
| | |
MedLine Citation:
|
PMID: 9640365 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The T-cell activation antigen CD26 or dipeptidyl-peptidase IV (DPP-IV) belongs to a group of membrane-bound proteases that are variably expressed by melanoma cell lines. In vitro studies have suggested that loss of CD26 is associated with tumour progression. To correlate its expression with the histological stage of tumour progression of malignant melanoma (MM), we studied the distribution of CD26/DPP-IV in paraffin sections of a series of 110 benign and malignant pigment-cell lesions of the skin using a cocktail of anti-CD26 monoclonal antibodies and the three-step ABC method. Only two of 44 benign lesions focally expressed CD26 in their junctional compartment. In MM, expression of CD26 was not related to any of the known histological prognostic factors, but was associated with the stage of tumour progression; thus, CD26 was expressed in the situ or invasive radial growth phase in 34% of MM, whereas only 12% of MM expressed CD26 in the vertical growth phase. No CD26 expression occurred in metastatic melanomas. These data suggest that this proteinase plays a part in the early invasion of MM. Thus, CD26 may serve in the binding to, and enzymatic degradation, components of the extracellular matrix of the papillary dermis. Loss of CD26 in the vertical growth phase may contribute to the insufficient inactivation of regulatory peptides and unlimited action of growth factors. |
| | |
Authors:
|
J J Van den Oord |
Related Documents
:
|
10737605 - Expression of t-cadherin (cdh13, h-cadherin) in human brain and its characteristics as ... 21285945 - Jtv1 co-activates fbp to induce usp29 transcription and stabilize p53 in response to ox... 15245435 - Autocrine catecholamine biosynthesis and the beta-adrenoceptor signal promote pigmentat... 19288495 - Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant ... 19540845 - A novel molecular switch. 9821165 - A case of multiple system atrophy with hyperglycinaemia due to a selective deficiency o... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The British journal of dermatology Volume: 138 ISSN: 0007-0963 ISO Abbreviation: Br. J. Dermatol. Publication Date: 1998 Apr |
Date Detail:
|
Created Date: 1998-07-23 Completed Date: 1998-07-23 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0004041 Medline TA: Br J Dermatol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 615-21 Citation Subset: IM |
Affiliation:
|
Department of Pathology, University Hospitals, Katholieke Universiteit Leuven, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antigens, CD26
/
analysis* Antigens, Neoplasm / analysis* Disease Progression Humans Immunoenzyme Techniques Melanoma / enzymology*, pathology, secondary Nevus, Pigmented / enzymology* Skin Neoplasms / enzymology*, pathology |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, Neoplasm; EC 3.4.14.5/Antigens, CD26 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with ...
Next Document: The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin.